- New Guideline: Therapeutic Use of Medical Cannabis in New York State (1/25/22)
- Topics, Trends & Updates for January (1/13/22)
- Updated: COVID-19 Vaccine for Adults With HIV (1/12/22)
- Updated: Perioperative Care in Adults With HIV (11/16/21)
- Updated: Selecting An Initial ART Regimen (10/11/21)
- Updated: When to Initiate ART, With Protocol for Rapid Initiation (10/11/21)
- Updated: Diagnosis and Management of HIV-2 in Adults (10/11/21)
- FDA Limits Use of Certain Monoclonal Antibodies to Treat COVID-19 Due to the Omicron Variant (1/24/22)
- FDA Takes Actions to Expand Use of Treatment for Outpatients with Mild-to-Moderate COVID-19 (1/21/22)
- Free At-Home COVID-19 Tests (1/19/22)
- FDA Shortens Interval for Booster Dose of Moderna COVID-19 Vaccine to Five Months (1/7/22)
- FDA Takes Multiple Actions to Expand Use of Pfizer-BioNTech COVID-19 Vaccine (1/3/22)
- NYCDOHMH: mRNA COVID-19 Vaccines Preferred Over Johnson & Johnson (12/23/21)
- FDA EUA for Paxlovid for COVID-19 (12/23/21)
- HIVinfo: Updates to the Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV (1/24/22)
- HIVinfo: Updated Resources Available: Living with HIV and HIV and Specific Populations (1/21/22)
- AETC NCRC: January 2022 Monthly Update (1/19/22)
- CEI Newsletter (1/18/22)
- NYS Medicaid Update (1/6/22)
- HIVinfo: Updates to Recommendations for the Use of Antiretroviral Drugs During Pregnancy and Interventions to Reduce Perinatal HIV Transmission in the US (12/30/21)
- FDA Approves First Injectable Treatment for HIV Pre-Exposure Prevention (12/20/2021)
The New York State Department of Health (NYSDOH) AIDS Institute (AI) Clinical Guidelines Program is a longstanding, collaborative effort of the AI Office of the Medical Director and the Johns Hopkins University School of Medicine, Division of Infectious Diseases.
The program produces and publishes evidence-based, state-of-the-art clinical practice guidelines that establish uniform standards of care for NYS to improve the health and well-being of all adults who receive prevention services or treatment for HIV, viral hepatitis, other sexually transmitted infections, and substance use disorders.
Learn more: